Influence of quipazine, a potential anti-parkinsonian agent on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitro
- 16 September 1973
- journal article
- Published by Elsevier in Life Sciences
- Vol. 13 (6) , 685-691
- https://doi.org/10.1016/0024-3205(73)90285-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Drug Therapy of ParkinsonismNew England Journal of Medicine, 1972
- Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.Life Sciences, 1972
- Parkinson's diseaseNeurology, 1972
- Metabolic Modification of Parkinson's Disease and of Chronic Manganese PoisoningAnnual Review of Medicine, 1971
- Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of ActionScience, 1969
- Similarities between the pharmacological actions of quipazine and serotoninEuropean Journal of Pharmacology, 1969
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966
- Disposition of S35-Prochlorperazine in the RatJournal of Pharmaceutical Sciences, 1964
- Body size and tissue respirationBiochimica et Biophysica Acta, 1950